Burning Rock Biotech Limited (NASDAQ: BNR) Stock Information | RedChip

Burning Rock Biotech Limited (NASDAQ: BNR)


$5.3500
-0.0300 ( -2.55% ) 10.2K

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Market Data


Open


$5.3500

Previous close


$5.3800

Volume


10.2K

Market cap


$55.01M

Day range


$5.3650 - $5.6590

52 week range


$2.6200 - $9.9870

SEC Filings


Form Type Description Pages Date
6-k Form 6-K 2 Mar 28, 2024
6-k Form 6-K 2 Jan 04, 2024
6-k Form 6-K 2 Dec 20, 2023
6-k Form 6-K 2 Nov 30, 2023
6-k Form 6-K 4 Nov 22, 2023

Latest News